Last reviewed · How we verify
beta-tricalcium phosphate bone substitute
beta-tricalcium phosphate bone substitute is a Biologic drug developed by Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre. It is currently FDA-approved. Also known as: cerasorb, sorbone.
At a glance
| Generic name | beta-tricalcium phosphate bone substitute |
|---|---|
| Also known as | cerasorb, sorbone |
| Sponsor | Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of the Safety and Performance of the Neobone®: A Prospective Observational Study in Dental Area
- Clinical Study to Evaluate Adaptos®Ortho Wedge Bone Graft Substitute in High Tibial Osteotomy (NA)
- Study on Safety and Performance of AdvanCore Bone Void Filler (NA)
- Evaluation of Platelet Rich Fibrin / Biphasic Calcium Phosphate Effect Versus Autogenous Bone Graft on Reconstruction of Alveolar Cleft (NA)
- Biphasic Material With PRF in Lateral Sinus Floor Augmentation (PHASE1)
- Comparison of Bioactive Glass and Beta-Tricalcium Phosphate as Bone Graft Substitute
- Furcation Therapy With Enamel Matrix Derivative (NA)
- Ridge Preservation With Moldable Beta-tricalcium Phosphate Bone Substitute on Non-containable Non-Molar Extraction Sites (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- beta-tricalcium phosphate bone substitute CI brief — competitive landscape report
- beta-tricalcium phosphate bone substitute updates RSS · CI watch RSS
- Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre portfolio CI
Frequently asked questions about beta-tricalcium phosphate bone substitute
What is beta-tricalcium phosphate bone substitute?
beta-tricalcium phosphate bone substitute is a Biologic drug developed by Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre.
Who makes beta-tricalcium phosphate bone substitute?
beta-tricalcium phosphate bone substitute is developed and marketed by Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre (see full Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre pipeline at /company/panineeya-mahavidyalaya-institute-of-dental-sciences-research-centre).
Is beta-tricalcium phosphate bone substitute also known as anything else?
beta-tricalcium phosphate bone substitute is also known as cerasorb, sorbone.
What development phase is beta-tricalcium phosphate bone substitute in?
beta-tricalcium phosphate bone substitute is FDA-approved (marketed).
Related
- Manufacturer: Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre — full pipeline
- Also known as: cerasorb, sorbone
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing